PATENT CLAIM ANALYSIS

Application Number: 15887838
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["546", "243000"]

Abstract:
Provided are 4′-O substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Claim (Index 34):
A method of treating, managing or preventing a disease or disorder comprising administering to a patient a compound of  claim 30 , or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein the disease or disorder is cancer, a disorder associated with angiogenesis, pain, macular degeneration or a related syndrome, a skin disease, a pulmonary disorder, an asbestos-related disorder, a parasitic disease, an immunodeficiency disorder, a CNS disorder, CNS injury, atherosclerosis or a related disorder, dysfunctional sleep or a related disorder, an infectious disease, hemoglobinopathy or a related disorder, or a TNF\u03b1 related disorder.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.45833
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12077715', '14083205', '14552337', '13410216', '14749448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7909093859151834
- 35 USC 102 Novelty (BERT): 0.5197458642694707
- Combined Prediction Score: 0.7637930337506122
- Mean Citation Score: 314.21538
- Max Citation Score: 318.32416
- Similarity Product: 204.32698561111445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test